Health Pharma Professional Research S.A. de C.V.
México 3810
0 studies enrolling now · 4 studies all time
What they study most
Carcinoma, Non-Small-Cell Lung, Diabetes Mellitus, Type 2, Non-small Cell Lung Cancer, Solid Tumors
Studies at this site
- Avelumab Program Rollover Study — Running, not enrolling
- Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer — Running, not enrolling
- Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200) — Completed
- Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA) — Completed